Healthcare provider profile · identity verified

Elizabeth Spellmeyer, NP

Nurse Practitioner · EUREKA, CA · NPI 1194126680

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	218	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	213	45
Atorvastatin Calcium	Atorvastatin Calcium	161	39
Duloxetine Hcl	Duloxetine Hcl	121	19
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	111	12
Morphine Sulfate Er	Morphine Sulfate	107	11
Lisinopril	Lisinopril	106	21
Levothyroxine Sodium	Levothyroxine Sodium	101	27
Metoprolol Succinate	Metoprolol Succinate	100	21
Losartan Potassium	Losartan Potassium	96	21
Metformin Hcl Er	Metformin Hcl	92	21
Albuterol Sulfate Hfa	Albuterol Sulfate	89	27
Omeprazole	Omeprazole	85	23
Famotidine	Famotidine	83	17
Lorazepam	Lorazepam	82	19
Amlodipine Besylate	Amlodipine Besylate	81	21
Ibuprofen	Ibuprofen	80	17
Jardiance	Empagliflozin	78	suppressed
Mirtazapine	Mirtazapine	72	19
Pantoprazole Sodium	Pantoprazole Sodium	72	16
Rosuvastatin Calcium	Rosuvastatin Calcium	72	26
Fluticasone Propionate	Fluticasone Propionate	69	25
Sertraline Hcl	Sertraline Hcl	69	21
Trazodone Hcl	Trazodone Hcl	66	15
Ozempic	Semaglutide	61	suppressed
Baclofen	Baclofen	59	14
Tamsulosin Hcl	Tamsulosin Hcl	56	13
Bupropion Xl	Bupropion Hcl	53	suppressed
Pregabalin	Pregabalin	53	12
Ondansetron Odt	Ondansetron	52	11
Clonazepam	Clonazepam	51	suppressed
Furosemide	Furosemide	48	15
Metformin Hcl	Metformin Hcl	47	17
Acetaminophen-Codeine	Acetaminophen With Codeine	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	11
Hydrochlorothiazide	Hydrochlorothiazide	43	11
Montelukast Sodium	Montelukast Sodium	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Naproxen	Naproxen	33	suppressed
Nitroglycerin	Nitroglycerin	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Eliquis	Apixaban	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	14
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	11
Simvastatin	Simvastatin	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Varenicline Tartrate	Varenicline Tartrate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Diazepam	Diazepam	25	suppressed
Eszopiclone	Eszopiclone	25	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Nystatin	Nystatin	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Prednisone	Prednisone	21	11
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Armour Thyroid	Thyroid,pork	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Lurasidone Hcl	Lurasidone Hcl	17	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Topiramate	Topiramate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Finasteride	Finasteride	15	suppressed
Lactulose	Lactulose	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Dotti	Estradiol	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Glyburide	Glyburide	12	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Lamotrigine Er	Lamotrigine	11	suppressed
Lithium Carbonate Er	Lithium Carbonate	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error